Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249
What this trial is testing

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 731
Early research (Phase 1)Looking for participantsNCT07660432
What this trial is testing

SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms, Malignant
Jiangsu Simcere Pharmaceutical Co., Ltd. 472
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714395
What this trial is testing

Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Actuate Therapeutics Inc. 100
Testing effectiveness (Phase 2)Looking for participantsNCT07399769
What this trial is testing

Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors

Who this might be right for
Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)
Shenzhen University General Hospital 20
Early research (Phase 1)Study completedNCT03641586
What this trial is testing

The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor

Who this might be right for
Solid Tumors
BeiGene 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06873854
What this trial is testing

LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Limited 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Not applicableUnknownNCT03047811
What this trial is testing

The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Fudan University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06470971
What this trial is testing

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm
Yuanquan Yang 40
Early research (Phase 1)Looking for participantsNCT06878612
What this trial is testing

A Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid Tumors

Who this might be right for
PolyphenolsCancer VaccineAdvanced Solid Tumor
Xingchen Peng 9
Large-scale testing (Phase 3)UnknownNCT01914107
What this trial is testing

Real-time Cancer Pain Assessment and Intervention

Who this might be right for
MalignancyPain
Sun Yat-sen University 200
Large-scale testing (Phase 3)Looking for participantsNCT07044336
What this trial is testing

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Who this might be right for
Endometrial CancerMalignant Solid Tumour
AstraZeneca 800
Early research (Phase 1)Looking for participantsNCT07656116
What this trial is testing

Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 27
Early research (Phase 1)Not Yet RecruitingNCT07110363
What this trial is testing

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

Who this might be right for
Advanced Malignant Solid TumorAdvanced Lung CancerNon-Small Cell Lung Cancer+1 more
Biotroy Therapeutics 58
Early research (Phase 1)Active Not RecruitingNCT04616534
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+19 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439357
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT01482377
What this trial is testing

RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin

Who this might be right for
Neoplasms
Hoffmann-La Roche 145
Early research (Phase 1)Active Not RecruitingNCT03842228
What this trial is testing

Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Study completedNCT00810394
What this trial is testing

Sorafenib in Treating Patients With Advanced Malignant Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 50
Next Page